Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

Thermo Fisher Scientific (TMO) reports Q4 earnings of ... Bibhu Pattnaik Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending ...

Thermo Fisher returned to growth in 4Q 2024 across ... While the Life Sciences Tools and Services industry has gone through a period of unsustainable growth during the pandemic followed by a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Thermo Fisher Scientific Inc. TMO slid 1.66% to $572.71 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Thermo Fisher Scientific. Looking at options history for Thermo Fisher Scientific TMO we detected 21 trades.

Thermo Fisher Scientific has launched the Invitrogen™ EVOS™ S1000 Spatial Imaging System, designed to help researchers ...

Thermo Fisher Scientific Inc.'s TMO fourth-quarter 2024 adjusted earnings per share (EPS) of $6.10 beat the Zacks Consensus Estimate by 2.9%. The figure increased 7.6% year over year. Find the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...